Study S001429

Using Secondary Data to Evaluate Sex-based Heterogeneity of GLP-1 Agonists and SGLT2 Inhibitors on Cardiovascular-Kidney-Metabolic Health (CKMH) Outcomes in Real-world Settings (DASH-CKMH)

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT07188545
Acronym: DASH-CKMH
Study type: OBSERVATIONAL
Status: ACTIVE_NOT_RECRUITING
Enrollment: 23280000
Start: 2025-09-15
Primary completion: 2029-06-30
Lead sponsor: Ohio State University
Conditions: Cardiovascular Kidney Metabolic Syndrome
Interventions: DRUG:Intervention; DRUG:Active Comparator
Results posted: FALSE
Individual participant data sharing: NO

Registered primary outcomes

3-Point major adverse cardiovascular event (3P-MACE) [Up to 5 years]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.